Abstract
Lymphocytes undergo metabolic reprogramming in inflammatory conditions generated by chronic, systemic, and metabolic diseases, in an attempt to offer an effective immune response to the body. In the tumor environment, cancer cells compete with lymphocytes for glucose and glutamine, suppressing the energy supply of T cells and impairing their effector function. The metabolic reprogramming …